(Q53677060)

17 May 2018

title

Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. (English)

1 reference

17 May 2018

1 reference

Jagasia MH

1

1 reference

17 May 2018

Greer JP

2

1 reference

17 May 2018

Morgan DS

3

1 reference

17 May 2018

Mineishi S

4

1 reference

17 May 2018

Kassim AA

5

1 reference

17 May 2018

Ruffner KL

6

1 reference

17 May 2018

Chen H

7

1 reference

17 May 2018

Schuening FG

8

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 June 2005

1 reference

17 May 2018

Bone Marrow Transplantation

published in

1 reference

17 May 2018

volume

35

1 reference

17 May 2018

issue

12

1 reference

17 May 2018

page(s)

1165-1169

1 reference

17 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704994

exact match

0 references

cites work

A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

Pegylation: engineering improved biopharmaceuticals for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

inferred from DOI database lookup

7 January 2021

based on heuristic

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

inferred from DOI database lookup

7 January 2021

based on heuristic

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704994

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1704994

1 reference

17 May 2018

1 reference

17 May 2018